Full-Time

Investor AI

Samsung Next

Samsung Next

201-500 employees

Venture funding for AI and healthtech

Compensation Overview

$175k - $195k/yr

Mountain View, CA, USA

Hybrid

Hybrid role requiring regular in-office days; occasional travel and early/late meetings.

Category
Finance & Banking (1)
Required Skills
Blockchain
Requirements
  • Undergraduate or an advanced degree in computer science, or engineering related field
  • Highly successful 3+ years of full time technical experience from industry or startups, or equivalent experience if this has been gained parallel to your research for an advanced technical degree
  • Strong domain knowledge of an area of tech focus for Samsung Next - specifically seeking AI, Robotics, Edge/Cloud Infrastructure expertise
  • Genuinely intellectually curious and passion for technology and startups
  • Thrives at playing many positions in an unstructured environment
  • Proven ability to develop and maintain strong relationships, particularly in the startup ecosystem
  • Displays high EQ and is a team oriented contributor
  • Outstanding analytical and communication skills - able to simplify the complex, synthesize information and provide pointed insights
  • Available to travel regularly
  • Previous angel or personal investing background a plus
  • Experience navigating in a large corporate organization is a plus
Responsibilities
  • Source investment opportunities. This will first and foremost involve growing, establishing and leveraging strong relationships with founders and investors in our key focus areas of AI, robotics, edge infrastructure, blockchain, healthtech, mediatech, and fintech
  • Evaluate early-stage investment opportunities with thorough due diligence on technology, team, market, and product
  • Communicate investment cases effectively from deal discussion through deal closure
  • Contribute to learnings and insights by developing a sharp and informed point of view communicated through written investment memos and active participation in deal discussion
  • Provide a supportive and responsive experience to the founders and builders we work with
Desired Qualifications
  • Previous angel or personal investing background a plus
  • Experience navigating in a large corporate organization is a plus

Samsung Next funds and supports bold founders building transformative technologies in AI, intelligent machines, healthtech, consumer services, and frontier tech. It operates as Samsung’s corporate venture arm, providing capital, mentorship, and hands-on support to help startups scale, with access to Samsung’s resources, customers, and global network. The product is not a consumer app but a service for startups: funding combined with operational help, go-to-market support, and strategic partnerships that leverage Samsung’s platforms. The company differentiates itself through its tight integration with a global hardware and consumer electronics giant, enabling portfolio companies to pilot, validate, and deploy at scale within Samsung’s ecosystem. Its goal is to identify and back ambitious founders whose technologies can transform industries and eventually reach widespread adoption through Samsung’s reach and infrastructure.

Company Size

201-500

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Mountain View, California

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • AI agent proliferation drives sustained demand for specialized inference infrastructure through 2027.
  • Beacon Biosignals and Nucleus Genomics capture preventive health market exceeding $100 billion.
  • World models enable robotics, gaming, and defense applications with massive TAM expansion.

What critics are saying

  • DeepInfra and Parasail cannibalize each other; Samsung Next forced to choose winner.
  • OpenAI, Google, Meta undercut inference pricing 30-40%, collapsing portfolio unit economics.
  • Nucleus Genomics fails securing payer contracts by Q4 2026; business model collapses.

What makes Samsung Next unique

  • Samsung Next backs AI inference infrastructure leaders processing trillions tokens weekly.
  • Portfolio spans biotech diagnostics, world models, and genomics with strategic Samsung integration.
  • Invests in purpose-built, cost-optimized platforms competing against generalist cloud providers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Flexible Work Hours

Company News

Yahoo Finance
Apr 6th, 2026
Beacon Biosignals upsizes Series B to $97M to advance at-home EEG brain health diagnostics

Beacon Biosignals has extended its Series B financing to $97 million, bringing total funding to over $132 million. The upsized round includes new investors JSL Health, Palo Santo VC, Kicker Ventures and Samsung Next. The Boston-based company combines FDA-cleared wearable EEG technology with AI to capture and analyse brain data for neurology, psychiatry and sleep medicine applications. The additional capital will accelerate Beacon's development of at-home EEG and advanced analytics for diagnostics, clinical trials and precision medicine. The original $86 million Series B was led by healthcare and technology investors including Innoviva, GV, S32, Catalio Capital Management, General Catalyst, Logos Capital, Casdin Capital and Indicator Ventures. The platform provides clinicians and biopharma partners with objective measures of brain function.

Business Wire
Mar 26th, 2026
Xona Closes $170M Series C to Lead Next Era of Global Navigation

Xona, building the next era of global positioning, navigation, and timing (PNT) infrastructure, today announced $170 million Series C funding.

FinancialContent
Mar 26th, 2026
Xona raises $170M Series C to build commercial GPS upgrade with new California factory

Xona, a commercial space company building positioning, navigation and timing infrastructure, has raised $170 million in an oversubscribed Series C round led by Mohari Ventures Natural Capital. Participants include Craft Ventures, ICONIQ, Woven Capital, NGP Capital, Samsung Next and Hexagon. The company is developing Pulsar, a navigation service broadcast from low Earth orbit satellites with stronger signals and military-grade encryption, compatible with existing GPS devices. Over a dozen commercial receiver partners are tracking Pulsar signals, with early customers expected to benefit from coverage by 2027. The funding will accelerate constellation deployment and manufacturing scale-up at Xona's new Burlingame, California factory. At full production, the company aims to manufacture more navigation satellites weekly than the US currently produces annually, deploying its 258-satellite constellation within a few years.

The Tech Buzz
Mar 17th, 2026
Samsung Ventures Backs Grid Beyond's Power Grid Tech

Island startup Grid Beyond lands Samsung investment for grid-balancing software

Femtech Insider
Feb 25th, 2026
Samsung Next invests in Nucleus Genomics' $499 whole-genome sequencing platform

Nucleus Genomics, a clinical-grade whole-genome sequencing platform, has received a strategic investment from Samsung Next, following a $14 million Series A led by Founders Fund and Seven Seven Six. The company offers a $499 physician-ordered test sequencing approximately 100% of a patient's DNA, covering over 2,000 diseases through a CLIA-certified, CAP-accredited US lab. Nucleus recently acquired Cambrean, an AI-powered wearable health platform, to combine continuous biometric data with genetic baselines. Samsung Next cited the company's scientific rigour and potential as a genetic baseline layer for wearables and health sensors. The company initially drew attention with its Nucleus Embryo product, allowing IVF patients to compare embryos based on traits including appearance and cognitive ability. Nucleus now appears to be repositioning as a broader preventive health genomics platform.